Promoters Acquire Additional Stake in Indoco Remedies via Open Market
Indoco Remedies Ltd 路 Acquisition/ Disposal of Shares 路 03 Nov 2026, 11:15 pm
Promoters Acquire Additional Stake in Indoco Remedies via Open Market Indoco Remedies' promoter group members, Aditi M. Panandikar and Madhura Suresh Kare, acquired 8,004 equity shares (0.009% stake) via open market purchases between 30th Oct'26 and 2nd Nov'26. Individually, Aditi Panandikar bought 4,000 shares, increasing her stake from 3.173% (29,29,128 shares) to 3.177% (29,33,128 shares), while Madhura Kare acquired 4,004 shares, raising her holding from 2.699% (24,91,413 shares) to 2.703% (24,95,417 shares). Consequently, their combined promoter holding increased from 5.872% (54,20,541 shares) to 5.880% (54,28,545 shares). Total equity share capital remains unchanged at 9,23,18,455 shares.
Original exchange filing (PDF)
More announcements from Indoco Remedies Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others 路 13 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh G Kare 路 09 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh G Kare 路 07 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others 路 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ms. Aditi M Panandikar & Ms. Madhura Suresh Kare 路 04 Nov 2026
- Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30-09-2026 路 29 Oct 2026
- Audio recording of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September, 2026 路 27 Oct 2026
- Indoco''s Clinical Research Orgainsation - AnaCipher receives approval from ANVISA Brazil for its clinical and bioanalytical facilities 路 27 Oct 2026
